Allergan’s Boey Moves Closer to EU Approval for Glabellar Lines
North Chicago, Illinois, USA – May 21, 2026 Allergan Aesthetics, an AbbVie company and global leader in medical aesthetics,...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
North Chicago, Illinois, USA – May 21, 2026 Allergan Aesthetics, an AbbVie company and global leader in medical aesthetics,...
YOKNEAM, Israel – May 8, 2026 Lumenis announced that its groundbreaking hair restoration platform FoLix™ has received the Hair...
SEOUL, South Korea, Jan. 30, 2026 — Cynosure Lutronic announced the successful completion of European Union Medical Device Regulation...
Nashville, Tenn., January 13, 2026 — Revance and Teoxane announced that the U.S. Food and Drug Administration has approved...
Peabody, Massachusetts | December 30, 2025 — Cosmetics & Wellness MD, formerly known as CosmeticsMD, announced a strategic expansion...
Laval, QC — December 1, 2025 — Bausch Health’s aesthetics division, Solta Medical, has completed the acquisition of Wuhan...
